Literature DB >> 17316811

Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.

Wanny Basuki1, Makoto Hiromura, Hiromu Sakurai.   

Abstract

Zinc (Zn) is an essential trace element with multiple regulatory functions, involving insulin synthesis, secretion, signaling and glucose transport. Since 2000, we have proposed that Zn complexes with different coordination environments exhibit high insulinomimetic and antidiabetic activities in type 2 diabetic animals. However, the molecular mechanism for the activities is still unsolved. The purpose of this study was to reveal the molecular mechanism of several types of Zn complexes in 3T3-L1 adipocytes, with respect to insulin signaling pathway. Obtained results shows that bis(1-oxy-2-pyridine-thiolato)Zn(II), Zn(opt)2, with S(2)O(2) coordination environment induced most strongly Akt/protein kinase B (Akt/PKB) phosphorylation, in which the optimal phosphorylation was achieved at a concentration of 25 microM, and this Zn(opt)2-induced Akt/PKB phosphorylation was inhibited by wortmannin at 100 nM. Further, the phosphorylation was maximal at 5-10 min stimulation, in agreement with the Zn uptake which was also maximal at 5-10 min stimulation. The Akt/PKB phosphorylation was in concentration- and time-dependent manners. Zn(opt)2 was also capable to translocate GLUT4 protein to the plasma membrane. We conclude that Zn(opt)2 was revealed to exhibit both insulinomimetic and antidiabetic activities by activating insulin signaling cascade through Akt/PKB phosphorylation, which in turn caused the GLUT4 translocation from the cytosol to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316811     DOI: 10.1016/j.jinorgbio.2006.12.015

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  7 in total

1.  Identification of a potent activator of Akt phosphorylation from a novel series of phenolic, picolinic, pyridino, and hydroxamic zinc(II) complexes.

Authors:  Savvas N Georgiades; Lok Hang Mak; Inmaculada Angurell; Evelyn Rosivatz; M Firouz Mohd Mustapa; Christoulla Polychroni; Rudiger Woscholski; Ramon Vilar
Journal:  J Biol Inorg Chem       Date:  2010-10-23       Impact factor: 3.358

2.  The Structural Basis of Action of Vanadyl (VO2+) Chelates in Cells.

Authors:  Marvin W Makinen; Marzieh Salehitazangi
Journal:  Coord Chem Rev       Date:  2014-11-01       Impact factor: 22.315

3.  Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.

Authors:  Guillaume Chanoit; SungRyul Lee; Jinkun Xi; Min Zhu; Rachel A McIntosh; Robert A Mueller; Edward A Norfleet; Zhelong Xu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

4.  Molecular mechanism of antidiabetic zinc-allixin complexes: regulations of glucose utilization and lipid metabolism.

Authors:  Akihiro Nakayama; Makoto Hiromura; Yusuke Adachi; Hiromu Sakurai
Journal:  J Biol Inorg Chem       Date:  2008-02-21       Impact factor: 3.358

5.  Reciprocal control of pyruvate dehydrogenase kinase and phosphatase by inositol phosphoglycans. Dynamic state set by "push-pull" system.

Authors:  Patricia McLean; Sirilaksana Kunjara; A Leslie Greenbaum; Khalid Gumaa; Javier López-Prados; Manuel Martin-Lomas; Thomas W Rademacher
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

Review 6.  Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications.

Authors:  Priyanga Ranasinghe; Shehani Pigera; Priyadarshani Galappatthy; Prasad Katulanda; Godwin R Constantine
Journal:  Daru       Date:  2015-09-17       Impact factor: 3.117

Review 7.  Putative Key Role of Inositol Messengers in Endothelial Cells in Preeclampsia.

Authors:  Sirilaksana Kunjara; Patricia McLean; Laurens Rademacher; Thomas W Rademacher; Fabiana Fascilla; Stefano Bettocchi; Marco Scioscia
Journal:  Int J Endocrinol       Date:  2016-09-21       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.